Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combining Dexmedetomidine and Ketamine in Intensive Care Sedation: Efficacy and Safety

NCT04096768 is registered in ClinicalTrials.gov with Lebanese American University Medical Center as lead sponsor.

NCT NCT04096768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04096768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combining Dexmedetomidine and Ketamine in Intensive Care Sedation: Efficacy and Safety
Lead sponsor
Lebanese American University Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
September 16, 2019
Completion date
December 30, 2021
Enrollment
394 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

icu patients, sedation